Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 11.9.2023G.L. Pharma GmbH (GLH-2)7411BGerasa 100 mg gastrorezistentné tablety (tbl ent 100x100 mg (blis.PVC/Al))8.9.2023Z
 11.9.2023G.L. Pharma GmbH (GLH-2)68602Gerodorm (tbl 10x40 mg (blis.PVC/PVDC/Al))6.9.2023Z
 11.9.2023G.L. Pharma GmbH (GLH-2)20587Convulex CR 500 mg (tbl plg 100x500 mg (fľ.skl.hnedá))4.9.2023O
 11.9.2023Adamed Pharma S.A. (AFD)2961BRAMIZEK 5 mg/5 mg tvrdé kapsuly (cps dur 98x5 mg/5 mg (blis.PA/Al/PVC/Al))31.8.2023R
 11.9.2023Adamed Pharma S.A. (AFD)2983BRAMIZEK 10 mg/10 mg tvrdé kapsuly (cps dur 28x10 mg/10 mg (blis.PA/Al/PVC/Al))31.8.2023R
 11.9.2023Zentiva k.s. (ZNT-3)89295Bloonis 10 mg (tbl oro 28x10 mg (blis.OPA/Al/PVC/Al))18.9.2023O
 11.9.2023Zentiva, k.s. (ZNT-1)2509DZetovar 10 mg/20 mg tablety (tbl 90x10 mg/20 mg (blis.OPA/Al/PVC))11.9.2023O
 11.9.2023Zentiva, k.s. (ZNT-1)2513DZetovar 10 mg/40 mg tablety (tbl 90x10 mg/40 mg (blis.OPA/Al/PVC))11.9.2023O
 11.9.2023Zentiva, k.s. (ZNT-1)33494NEUROL 0,5 (tbl 30x0,5 mg (blis. PVC/PVDC/Al))12.9.2023O
 11.9.2023Zentiva, k.s. (ZNT-1)5328BZenaro 5 mg (tbl flm 90x5 mg (blis.PVC/PE/PVDC/Al))12.9.2023O
 11.9.2023Zentiva, k.s. (ZNT-1)5802BMixor 80 mg/5 mg (tbl 28x80 mg/5 mg (blis.OPA/Al/PVC/Al))12.9.2023O
 11.9.2023Incyte Biosciences Distribution B.V. (ICY-NL)6386AIclusig 45 mg filmom obalené tablety (tbl flm 30x45 mg (fľ.HDPE))4.9.2023R
 11.9.2023Incyte Biosciences Distribution B.V. (ICY-NL)6384AIclusig 15 mg filmom obalené tablety (tbl flm 60x15 mg (fľ.HDPE))11.9.2023O
 11.9.2023POLICHEM S.A. (PLC)81341Polinail (lum 1x3,3 ml (fľ. skl.))11.9.2023O
 11.9.2023ALPEX PHARMA (IRL) LIMITED (APX-IE)00115Oramellox 15 mg (tbl oro 30(3x10)x15 mg (blis.Al/PA/Al/PVC))4.9.2023R

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)